Expression systems
US10844402B2 · kind B2 · utility
2Cited by
18References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 13, 2018 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Jul 18, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A gene expression system is provided. The system comprises at least one coding sequence to be expressed in an organism, and at least one promoter operably linked thereto. It further comprises at least one splice control sequence which, in cooperation with a spliceosome, mediates alternative splicing of RNA transcripts of the coding sequence. The mediation of alternative splicing is in a sex-specific, stage-specific, germline-specific and tissue-specific manner.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.